It's Celgene

Discussion in 'Pfizer' started by anonymous, Apr 20, 2018 at 11:03 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    wait and see
     

  2. anonymous

    anonymous Guest

    Two dogs one cup.
     
  3. anonymous

    anonymous Guest

    Hope so and hope it’s soon.
     
  4. anonymous

    anonymous Guest

    what does Celgene have? Anything for primary care?
     
  5. anonymous

    anonymous Guest

    Scrotum nectar for your daughters fertilization
     
  6. anonymous

    anonymous Guest

    What does Pfizer have?
     
  7. anonymous

    anonymous Guest

    Celgene's got nothing and won't come near covering for the gaps at Pfizer. Need to go big to cover the spread!
     
  8. anonymous

    anonymous Guest

    CASH and lots of it!!!!!!!!!!!!
     
  9. anonymous

    anonymous Guest

    CELG stock way down maybe today’s the day
     
  10. anonymous

    anonymous Guest

  11. anonymous

    anonymous Guest

    Pretty sad, the only big news about Pfizer is who we’re buying and ultimately destroying.
     
  12. anonymous

    anonymous Guest

    How about Astellas? PFE would get all of Xtandi, plus a nugget or two from an otherwise-crappy pipeline.
    With the TakedaShire news, Astellas folks must be soiling their pants....
     
  13. anonymous

    anonymous Guest

    more like peeing... Vesicare for Overactive Bladder, anyone? It’s losing patent-protection this year. There goes another $1B in annual sales....
     
  14. anonymous

    anonymous Guest

    The Japanese gov’t wouldn’t let that deal go through.
     
  15. anonymous

    anonymous Guest

    All of eliquis is better.
     
  16. anonymous

    anonymous Guest

    All of Eliquis is also much much more expensive.
     
  17. anonymous

    anonymous Guest

    Celgene is at 54B. Will Pfizer scoop up?
     
  18. anonymous

    anonymous Guest

    Eliquis deal was to boost PFE top-line. Not for profitability. BMS got sweet deal, so makes sense for PFE to eat them.
     
  19. anonymous

    anonymous Guest

    No. Celgene 2 xpensive.
    Try Astellas. They are desperate after the Takeda news.
    One problem: Japanese protectionism.